Wave Life Sciences Ltd.
Ticker: 1631574
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q2 FY25 | Q1 FY25 | Q2 FY24 | Q1 FY24 | Q3 FY23 | Q2 FY23 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 2.27-94.1% | 38.25+339.7% | 8.70-5.2% | 9.18-53.4% | 19.69+57.0% | 12.54-74.5% | 49.21+122.6% | 22.11 |
| Total Income | 2.27-94.1% | 38.25+339.7% | 8.70-5.2% | 9.18-53.4% | 19.69+57.0% | 12.54-74.5% | 49.21+122.6% | 22.11 |
| EXPENSES | ||||||||
| Expenditure | 76.07+9.4% | 69.54+13.1% | 61.46+4.2% | 58.98+7.8% | 54.69+16.4% | 47.00+5.0% | 44.77-1.8% | 45.58 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00+100.0% | -0.68 | 0.00 |
| PROFIT | ||||||||
| PBT | -69.36-165.8% | -26.09+48.3% | -50.47-7.7% | -46.88-42.4% | -32.92-4.3% | -31.56-579.6% | 6.58+131.2% | -21.10 |
| Net Profit | -69.36-165.8% | -26.09+48.3% | -50.47-7.7% | -46.88-42.4% | -32.92-4.3% | -31.56-535.3% | 7.25+134.4% | -21.10 |
| KEY METRICS | ||||||||
| OPM % | -100.00%-18.17pp | -81.83%+18.17pp | -100.00% | -100.00% | -100.00% | -100.00%-109.03pp | 9.03%+109.03pp | -100.00% |
| NPM % | -100.00%-31.79pp | -68.21%+31.79pp | -100.00% | -100.00% | -100.00% | -100.00%-114.73pp | 14.74%+110.20pp | -95.47% |
| EPS | -0.34-161.5% | -0.13+58.1% | -0.31-6.9% | -0.29-16.0% | -0.25-4.2% | -0.24-442.9% | 0.07+135.0% | -0.20 |
Corporate Events
Board MeetingWVE
20267Aug
Board Meeting
Completion of Redomiciliation; Directors and executive offic…
SEC Filing ↗ Board MeetingWVE
202622Jun
Board Meeting
Shareholders to vote on a proposal to approve a Scheme of Ar…
SEC Filing ↗